Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis

Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis

Jun 17, 2020
Source URL: https://qa1.novartis.us/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis-0